Poor sleep is associated with up to seven years worth of increased heart disease risk and even premature death, according to a study. The research, published in the journal BMC Medicine, analysed data from more than 300,000 middle-aged adults from the UK Biobank. Researchers from the University of Sydney in collaboration with Southern Denmark University found that different disturbances to sleep are associated with different durations of compromised cardiovascular health later in life compared to healthy sleepers. In particular, men with clinical sleep-related breathing disorders lost nearly seven years of cardiovascular disease-free life compared to those without these conditions, and women lost over seven years, they said. The study found that even general poor sleep, such as insufficient sleep, insomnia, snoring, going to bed late, and daytime sleepiness is associated with a loss of around two years of normal heart health in men and women. "Our research shows that, over time, .
Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline modules
The company said it has introduced Sacubitril and Valsartan under two brand names, Valentas and Arnipin, in strengths of 200 mg, 100 mg, and 50 mg, in India
This kind of wearable device uses green light to detect blood flow beneath your skin and deduces your heart rate
IIT Kanpur is ready with an artificial heart that would be of great help to people with acute cardiac problems
A meta-analysis of 23 studies, including 854 patients aged 12 to 20 years with mRNA vaccine-associated myopericarditis, has found that the incidence was higher in males after the second dose
The Union health ministry has notified the inclusion of coronary stents in the National List of Essential Medicines, 2022, a move that will help make these life-saving medical devices more affordable. The move is based on the recommendations by an expert committee constituted to review the inclusion of stents in the list based on requirement. The National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents. On November 6, the Standing National Committee on Medicines (SNCM) had submitted its recommendation for inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022 in two categories -- Bare Metal Stents (BMS) and Drug Eluting Stents (DES) which include metallic DES and bioresorbable vascular scaffold (VBS)/biodegradable stents. According to minutes of the SNCM meeting, vice chairman Dr Y K Gupta stated that coronary stents were earlier included in NLEM, 2015 through a separate notification based on the recommendations of an
Covid can alter a person's genetic makeup which can enhance the proliferation of disease and cause further deterioration in diabetes and associated heart disease, an Indian-origin researcher revealed
It would be a major breakthrough if something like the Apple Watch could detect it passively or help diagnose it, the report added
Researchers in Berlin have spent decades on a peculiar hereditary illness that results in extraordinarily short fingers and incredibly high blood pressure in half of the members of specific families
Around 500 mn people will develop heart disease, obesity, diabetes or other non-communicable diseases (NCDs) due to physical inactivity, WHO's 'Global Status Report on Physical Activity 2022' says
There was a high incidence of potentially relevant genetic variants (63 per cent) among the patients, which has significant implications for their families
New Delhi [India], September 28 (ANI): Clearing the air around the effects of a booster dose of the vaccines, the health experts have said that there is no definite link between heart dysfunction and the precaution doses of the COVID shots.With social media flooded with questions revolving around the effects of booster dose on the human heart, the experts came out in defence of the vaccines.According to Dr Vivek Chaturvedi, Professor & HOD, Cardiology, Amrita Hospital, Faridabad, there have been some instances of heart-related issues in the patients after vaccination, however, there is no conclusive evidence to prove this."This is a very thorny question because we do see heart attacks happening. Not just attacks, sometimes fluid around the heart, sometimes Arrhythmias of the heart after vaccination. But it is very difficult to confirm this because these were happening in the past also," he said.However, Dr Vivek said that COVID can have effects on the heart and the person ...
The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the Pfizer-BioNTech Covid-19 vaccine, however the cases are rare and mild.
Brain stroke, heart-related issues have been on an uptick after the Covid-19 infectios, experts have said
Covid mRNA vaccines are associated with a decreased risk of death in patients with heart failure, says a new study
Exposure to high levels of air pollution is associated with a life-threatening heart condition, according to a study.
Researchers analysed medical data for nearly 1.3 million people treated for heart attacks and unstable angina at 2,239 hospitals in 318 Chinese cities between 2015 and 2020
Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market lvabradine tablets, used to treat heart failure, in the American market. The company has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for lvabradine tablets (5 mg and 7.5 mg), Alembic Pharmaceuticals said in a regulatory filing. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5 mg and 7.5 mg, of Amgen Inc. (Amgen). lvabradine Tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure. lvabradine Tablets are also indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate. According to IQVIA, ...
People who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to a study conducted in the US.